Real World Strategies for LDL-Mediated CV Risk Reduction in Vulnerable Diabetic Patients - Which Agents? In What Sequence? In Which Patient Subsets? A Case-Based Roadmap to Clinical Success with Statins, PCSK9 Inhibitors and Related Therapies
Registration
Real World Strategies for LDL-Mediated CV Risk Reduction in Vulnerable Diabetic Patients - Which Agents? In What Sequence? In Which Patient Subsets? A Case-Based Roadmap to Clinical Success with Statins, PCSK9 Inhibitors and Related Therapies
Would you like to continue where you left off?
Real World Strategies for LDL-Mediated CV Risk Reduction in Vulnerable Diabetic Patients - Which Agents? In What Sequence? In Which Patient Subsets? A Case-Based Roadmap to Clinical Success with Statins, PCSK9 Inhibitors and Related Therapies
